Summary
- Current Price
- As of today, DRUG price is $77.42, down -1.45% on
- Current Price All-Time High
- DRUG price is currently -37.44% below its historical high of $123.75 set on
- Market Cap
- DRUG current market cap is $760M, up +154.51% over the past 365 days
- Revenue
- DRUG current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for DRUG is on
Profile
| Metric | Value |
|---|---|
| Full Name | Bright Minds Biosciences Inc. |
| Ticker | NASDAQ: DRUG |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | brightmindsbio.com |
| Employees | 26 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $77.42 | |
| Price, 1D Change | -1.45% | |
| $760M | ||
| - | ||
| - | ||
| 1.72 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.27 | ||
| EPS, 1Y Change | -166.21% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:5 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.27 | ||
| EPS Estimate | - | |
| EPS Est. Change | - | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $77.42 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$1.47 | - | |
| - | -$0.48 | - | |
| - | -$1.27 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | $0.00 | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $77.42 | |
| $77.08 | ||
| $72.32 | ||
| $71.72 | ||
| $76.02 | ||
| $1.87 | ||
| 1.72 | ||
| $4.13 | ||
| 50.32 | ||
| 57.09% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.27 | ||
| -$55.00K | ||
| - | ||
| -$9.94M | ||
| - | ||
| -$8.75M | ||
| - | ||
| -$9.89M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 36.10 | ||
| 36.10 | ||
| - | ||
| - | ||
| 266.69 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 3.50 | ||
| -19.10 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $58.97M | ||
| $59.59M | ||
| $60.67M | ||
| $60.59M | ||
| $1.71M | ||
| $1.68M | ||
| $90.40K | ||
| $60.80K | ||
| $0.00 |
Expenses
| Metric | Value | Date |
|---|---|---|
| $8.75M | ||
| $9.89M | ||
| $55.00K | ||
| $0.00 | ||
| $55.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$6.22M | ||
| $0.00 | ||
| $61.19M | ||
| $0.00 | ||
| -$6.22M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| Jefferies | ||
| BTIG | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| BTIG | → | |
| BTIG | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with DRUG
FAQ
- What is the ticker symbol for Bright Minds Biosciences Inc.?
- The ticker symbol for Bright Minds Biosciences Inc. is NASDAQ:DRUG
- Does Bright Minds Biosciences Inc. pay dividends?
- No, Bright Minds Biosciences Inc. does not pay dividends
- What sector is Bright Minds Biosciences Inc. in?
- Bright Minds Biosciences Inc. is in the Healthcare sector
- What industry is Bright Minds Biosciences Inc. in?
- Bright Minds Biosciences Inc. is in the Biotechnology industry
- What country is Bright Minds Biosciences Inc. based in?
- Bright Minds Biosciences Inc. is headquartered in United States
- When did Bright Minds Biosciences Inc. go public?
- Bright Minds Biosciences Inc. initial public offering (IPO) was on March 22, 2021
- Is Bright Minds Biosciences Inc. in the S&P 500?
- No, Bright Minds Biosciences Inc. is not included in the S&P 500 index
- Is Bright Minds Biosciences Inc. in the NASDAQ 100?
- No, Bright Minds Biosciences Inc. is not included in the NASDAQ 100 index
- Is Bright Minds Biosciences Inc. in the Dow Jones?
- No, Bright Minds Biosciences Inc. is not included in the Dow Jones index
- When was Bright Minds Biosciences Inc. last earnings report?
- Bright Minds Biosciences Inc.'s most recent earnings report was on August 17, 2026
- When does Bright Minds Biosciences Inc. report earnings?
- The next expected earnings date for Bright Minds Biosciences Inc. is December 22, 2026
Data Sources & References
- DRUG Official Website brightmindsbio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1827401/000143774925038729/0001437749-25-038729-index.htm
- DRUG Profile on Yahoo Finance finance.yahoo.com/quote/DRUG
- DRUG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/drug